Dublin, Aug. 01, 2019 (GLOBE NEWSWIRE) -- The "Companion Animal Health Market Analysis By Animal Type, By Product (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics), By Distribution Channel, By End-use, And Segment Forecasts, 2014 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global companion animal health market is expected to reach USD 20.9 billion by 2025.

Increasing prevalence of zoonotic diseases is among high impact rendering drivers of this market. Various efforts are being undertaken at the country & regional levels by animal welfare organizations that works closely with various partners, including national ministries of health, World Organization for Animal Health (OIE), World Bank, Food and Agriculture Organization (FAO), and United Nations System Influenza Coordination (UNSIC). The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) is engaged in preventing, tracking, detecting, and responding to outbreaks of infectious diseases across the U.S. and other countries.

Growing investments by key market players to develop advanced solutions for pet care is one of the key contributors to the growth of the companion animal health market. For instance, regulatory departments in Brazil, South Africa, and India are helping various R&D centers by listing specific requirements of their countries. This has urged market players to initiate product development as per requirements of different countries. Key companies are actively focusing on innovation and development in pet care. For instance, Zoetis developed Cytopoint, the first monoclonal antibody for veterinary use for the treatment of atopic dermatitis in dogs.

Further Key Findings From the Report Suggest:

• Dogs accounted for the largest share of the animal type segment owing to health benefits associated with the adoption of pets, increase in awareness, and demand for efficient care for dogs
• The cats segment is anticipated to witness exponential growth owing to significant rise in the ownership for cats and greater cost-efficiency in comparison with the adoption of dogs
• Pharmaceuticals captured a substantial share of the product segment in 2016. Continuous advancements in drug formulations is responsible for boosting their uptake
• Diagnostics are expected to grow at an exponential rate owing to increasing zoonotic infections, which is likely to boost the need for the establishment of diagnostic laboratories and point-of-care testing
• Hospital pharmacies accounted for the substantial share of the distribution channels segment in 2016. High procedural volume, resulting from frequent readmission of pets for treatment, has supported the growth of this segment'
• Veterinary hospitals & clinics accounted for the largest share owing to availability of a wide range of treatment as well as diagnostic options

Key Topics Covered

Chapter 1. Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region wise market: base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-based Segment Share Calculation
1.3 List of Secondary Sources

Chapter 2 Executive Summary

Chapter 3 Companion Animal Health Market Variables, Trends & Scope
3.1 Market Segmentation& Scope
3.2 Market Driver Analysis
3.2.1 Rise in number of government initiatives
3.2.2 Technological advancements
3.3 Market Restraint Analysis
3.3.1 Increase in counterfeit drugs
3.3.2 Lack of standardization
3.4 Penetration & Growth Prospect Mapping
3.5 Companion Animal Health Market - SWOT Analysis, By Factor (Political & legal, economic, and technological)
3.6 Industry Analysis - Porter's
3.7 Value Chain Analysis
3.8 Investments in Animal Health
3.9 Pet Animal Owner Profiles
3.10 Current Regulatory Scenario
3.10.1 U.S.
3.10.2 Canada
3.11 Company Market Share, 2016

Chapter 4 Companion Animal Health Market: Animal Type Estimates & Trend Analysis
4.1 Companion Animal Health Market: Animal Type Movement Analysis
4.2 Dogs
4.3 Equine
4.4 Cats
4.5 Others

Chapter 5 Companion Animal Health Market: Product Estimates & Trend Analysis
5.1 Companion Animal Health Market: Product Movement Analysis
5.2 Vaccines
5.3 Pharmaceuticals
5.4 Feed Additives
5.5 Diagnostics
5.6 Others

Chapter 6 Global Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis
6.1 Companion Animal Health Market: Distribution Channel Movement Analysis
6.2 Retail
6.3 E-commerce
6.4 Hospital Pharmacies

Chapter 7 Companion Animal Health Market: End-use Estimates & Trend Analysis
7.1 Companion Animal Health Market: End-use Movement Analysis
7.2 Point-of-care/In-house Testing
7.3 Veterinary Hospitals & Clinics
7.4 Others

Chapter 8 Companion Animal Health Market: Regional Estimates & Trend Analysis
8.1 Companion Animal Health Market Shares By Country, 2016 & 2025
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Latin America
8.6 MEA

Chapter 9 Competitive Landscape
9.1 Company Profiles

• Merck Animal Health
• Ceva Sant Animale
• Vetoquinol S.A.
• Zoetis
• Boehringer Ingelheim GmbH
• Bayer AG
• Elanco
• Nutreco N.V.
• Virbac

For more information about this report visit https://www.researchandmarkets.com/r/5rpmc2

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.